EconPapers    
Economics at your fingertips  
 

Lead compounds for the development of SARS-CoV-2 3CL protease inhibitors

Sho Iketani, Farhad Forouhar, Hengrui Liu, Seo Jung Hong, Fang-Yu Lin, Manoj S. Nair, Arie Zask, Yaoxing Huang, Li Xing, Brent R. Stockwell (), Alejandro Chavez () and David D. Ho ()
Additional contact information
Sho Iketani: Columbia University Irving Medical Center
Farhad Forouhar: Columbia University Irving Medical Center
Hengrui Liu: Columbia University
Seo Jung Hong: Columbia University Irving Medical Center
Fang-Yu Lin: WuXi AppTec
Manoj S. Nair: Columbia University Irving Medical Center
Arie Zask: Columbia University
Yaoxing Huang: Columbia University Irving Medical Center
Li Xing: WuXi AppTec
Brent R. Stockwell: Columbia University
Alejandro Chavez: Columbia University Irving Medical Center
David D. Ho: Columbia University Irving Medical Center

Nature Communications, 2021, vol. 12, issue 1, 1-7

Abstract: Abstract We report the identification of three structurally diverse compounds – compound 4, GC376, and MAC-5576 – as inhibitors of the SARS-CoV-2 3CL protease. Structures of each of these compounds in complex with the protease revealed strategies for further development, as well as general principles for designing SARS-CoV-2 3CL protease inhibitors. These compounds may therefore serve as leads for the basis of building effective SARS-CoV-2 3CL protease inhibitors.

Date: 2021
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/s41467-021-22362-2 Abstract (text/html)

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22362-2

Ordering information: This journal article can be ordered from
https://www.nature.com/ncomms/

DOI: 10.1038/s41467-021-22362-2

Access Statistics for this article

Nature Communications is currently edited by Nathalie Le Bot, Enda Bergin and Fiona Gillespie

More articles in Nature Communications from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().

 
Page updated 2025-03-19
Handle: RePEc:nat:natcom:v:12:y:2021:i:1:d:10.1038_s41467-021-22362-2